Drug Trial Radar · NCT04892173
JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC
Last checked: Nov 20, 2026Latest source record: Nov 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
500
Planned (sponsor's estimate)
Start
Dec 10, 2021
Primary completion
Jun 30, 2028
Study completion Jun 30, 2028
Sponsor
- Lead sponsor
- Johnson & Johnson Enterprise Innovation Inc.Johnson & Johnson (Janssen) (JNJ)
- Sponsor type
- Industry
- First posted
- May 19, 2021
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 60 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a global, open-label, randomized, 2-arm, Investigator's choice Phase 3 (Pivotal Stage) study to investigate the efficacy and safety of JNJ-90301900 (NBTXR3) / radiation therapy (RT)±cetuximab versus RT±cetuximab in treatment-naïve, platinum-ineligible, elderly participants with locally advanced head and neck squamous cell carcinoma (LA-HNSCC).
Conditions
- Carcinoma, Squamous Cell
Interventions
JNJ-90301900 (NBTXR3)Drug
Suspension of inert, crystalline hafnium oxide particles, designed to generate oxygen free radicals to destroy cancer cells after activation by ionizing radiation.
CetuximabDrug
Solution for infusion
Radiation TherapyRadiation
Intensity-modulated radiation therapy (IMRT): 70 Gray in 35 fractions over a 7-week period.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Progression-free Survival (PFS) Based on Independent Central Review (ICR)Time frame: 30 months following first randomized participant
Locations
196 sites in 27 countries. Site status is shown where the registry gives one.
University of Alabama at Birmingham
Birmingham, Alabama · Recruiting
City of Hope
Duarte, California · Recruiting
University of California at San Diego Moores Cancer Center
La Jolla, California · Recruiting
Memorial Radiation Oncology Medical Group Laguna Hills
Laguna Hills, California · Completed
UCLA Hematology Oncology
Los Angeles, California · Recruiting
Hoag Memorial Hospital
Newport Beach, California · Completed
University of California San Francisco
San Francisco, California · Recruiting
George Washington University Cancer Center
Washington D.C., District of Columbia · Recruiting
Mayo Clinic Jacksonville
Jacksonville, Florida · Recruiting
AdventHealth Orlando
Orlando, Florida · Recruiting
Moffitt Cancer Center
Tampa, Florida · Recruiting
Emory University Hospital Midtown
Atlanta, Georgia · Recruiting
University of Kentucky Markey Cancer Center
Lexington, Kentucky · Recruiting
Boston Medical Center
Boston, Massachusetts · Recruiting
Christus St. Vincent Regional Cancer Center
Santa Fe, New Mexico · Completed
Herbert Irving Comprehensive Cancer Center Columbia University Medical Center
New York, New York · Completed
Richmond University Medical Center
Staten Island, New York · Recruiting
Montefiore Medical Center
The Bronx, New York · Recruiting
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina · Recruiting
Atrium Health Levine Cancer Institute
Charlotte, North Carolina · Recruiting
University of Cincinnati
Cincinnati, Ohio · Recruiting
Stephenson Cancer Center
Oklahoma City, Oklahoma · Recruiting
Oregon Health And Science University
Portland, Oregon · Recruiting
University of Pennsylvania Perelman Center for Advanced Medicine
Philadelphia, Pennsylvania · Recruiting
University of Virginia
Charlottesville, Virginia · Recruiting
Macon Joan Brock Virginia Health Sciences Eastern Virginia Medical Group at Old Dominion University
Norfolk, Virginia · Recruiting
Medizinische Universitat Graz
Graz, Austria · Completed
Medical University Innsbruck
Innsbruck, Austria · Recruiting
Ordensklinikum Linz GmbH Barmherzige Schwestern
Linz, Austria · Recruiting
Medizinische Universitaet Wien
Vienna, Austria · Recruiting
Cliniques Universitaires Saint Luc
Brussels, Belgium · Recruiting
Grand Hopital De Charleroi Site Les Viviers
Charleroi, Belgium · Completed
Universitair Ziekenhuis Leuven
Leuven, Belgium · Recruiting
Fundacao Pio XII
Barretos, Brazil · Recruiting
Nucleo de Ensino e Pesquisa do Instituto Mario Penna
Belo Horizonte, Brazil · Recruiting
Centro Regional Integrado de Oncologia CRIO
Fortaleza, Brazil · Completed
Instituto Do Cancer Do Ceara
Fortaleza, Brazil · Recruiting
Fundacao Sao Francisco Xavier
Ipatinga, Brazil · Recruiting
Fundacao Doutor Amaral Carvalho
Jaú, Brazil · Recruiting
Hospital do Cancer de Londrina
Londrina, Brazil · Recruiting
Showing 40 of 196 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.